Monitoring changes in the number of living circulating tumor cells shows the effectiveness of the therapy and correlates with the further course of the cancer.

With the maintrac® drug sensitivity test, it can be examined how your circulating tumor cells respond to various chemotherapeutic agents – for a more targeted treatment.

maintrac® examines therapy-relevant characteristics of your tumor cells and helps to identify which maintenance therapy may be useful for you – individual and targeted.

maintrac® drug sensitivity testing evaluates in vitro the effect of various substances directly on viable circulating tumor cells. This allows identification of the most effective individual therapy and enables a personalized treatment tailored specifically to each patient.

maintrac® analysis of therapy-relevant charakteristics enables the identification of specific markers on circulating tumor cells that provide insights into the response to various therapies. This supports personalized therapy planning and helps select the most effective treatment options for the patient.

stemtrac® tumorspheres is a functional test for the detection of circulating cancer stem cells. The number of tumorspheres is associated with the aggressiveness of the primary tumor and the risk of disease progression. The test helps assess the metastatic potential of the tumor and supports personalized oncology treatment.

On this page we will keep you updated about upcoming events which we are participating.